The progression of NASH has a strong genetic component, the most robust of which is a single nucleotide polymorphism (SNP) (rs738409 C->G; p.I148M) in the patatin-like phospholipase domain-containing 3 (PNPLA3) gene. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatohepatitis.